4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001193125-26-274305
Chief Executive Officer acquired 7,761 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Weis Holger Chief Executive Officer | 2026-06-12 | Grant or award | +7,761 | $2.26 | $17,540 | 12,672 | D: show line 1 in the form |
Loading xslF345X06/ownership.xml…